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Abstract 
Optimizing the use of new tools, such as vaccines, may play a crucial role 
in reaching global targets for tuberculosis (TB) control. Some of the most 
promising candidate vaccines target adults. However, high-coverage mass 
vaccinations may be logistically more challenging for adults than for children. 
Vaccine delivery strategies targeting high-risk groups or settings might yield 
proportionally greater impact than strategies that target the general population. 
We developed an individual-based TB transmission model representing a 
hypothetical population consisting of South African gold miners and the 
associated labor-sending communities. We simulated implementation of a 
post-infection adult vaccine with 60% efficacy and mean 10-year duration of 
effect, and compared the impact of a mine-targeted vaccination strategy, 
where miners were vaccinated while in the mines, against a community-
targeted strategy, where random individuals within the labor-sending 
communities were vaccinated. Mine-targeted vaccination averted an estimated 
0.37 TB cases per vaccine dose, versus 0.25 for community-targeted 
vaccination, for a relative efficacy of 1.46 (95% range: 1.13-1.91). The added 
benefit of mine-targeted vaccination primarily reflected the disproportionate 
demographic burden of TB among adult males as a whole. As novel vaccines 
for TB are developed, venue-based vaccine delivery targeting high-risk 
demographic groups may improve both feasibility and transmission impact. 
Keywords: Tuberculosis, TB vaccine, Mathematical modeling, South African gold mines, 
Targeted vaccination  
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Introduction 
Effective tuberculosis (TB) vaccines have the potential to facilitate significant progress in 
reducing the global burden of TB [1], which is the leading infectious cause of human 
mortality [2]. There are numerous candidate vaccines in the pipeline, and many of the most 
promising candidates target adolescents and adults [3]. Adult vaccines are projected to have 
the greatest impact on TB incidence [4], but unlike with infant vaccines where mass 
vaccinations with high coverage are common, it may be logistically challenging to achieve 
similarly high coverage with adult vaccines. Furthermore, vaccine supplies for any TB 
vaccine are likely to be severely constrained during the initial roll-out phase. Hence, it is 
important to deliver adult vaccines in ways that maximize impact on TB incidence given a 
limited number of vaccine doses.  
One potential method for optimizing vaccine delivery is to target settings that foster M. 
tuberculosis transmission, such as crowded and poorly ventilated settings. These 
transmission “hotspots” may play a disproportionately large role in TB transmission 
because the majority of transmission events may occur within these settings [5,6]. The gold 
mines of South Africa are a widely recognized transmission hotspot for TB, with reported 
incidence in the past up to 3,000-5,000 per 100,000 per year [7-9]. Just as targeted vaccine 
delivery has been successful against other geographically heterogeneous infections (e.g., 
cholera [10,11], malaria [12,13], foot-and-mouth disease [14]), TB vaccine delivery 
strategies that target mines might yield proportionally greater impact than strategies that 
target the broader population, as the same number of doses could avert a larger number of 
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secondary transmission events. Not only might miners be at higher risk of acquiring TB, but 
mines as “hotspots” might also fuel epidemics in the overall community, and targeting such 
hotspots may beneficial to communities as a whole [15].  Furthermore, mining companies 
routinely offer occupational health services to their employees, which may provide a 
logistically simplified and less costly approach to large-scale vaccine delivery in a very 
high-risk population.  
In order to understand the impact of different vaccination targeting strategies, an important 
first step is to quantify the impact of a feasible targeting strategy in an epidemiologically 
relevant setting, relative to simply targeting high-risk communities as a whole. In this study, 
we aimed to estimate the relative impact of occupationally targeted vaccine delivery 
strategies centered on the South African gold mines. We modeled and calibrated a 
hypothetical population that consisted of the mines and the labor-sending communities from 
which the mining workforce is recruited. We compared two vaccination strategies: a mine-
targeted strategy, where vaccines were delivered to those working in the mines, and a 
community-targeted strategy, where vaccines were delivered to randomly selected adults in 
the labor-sending communities. The primary outcome (TB cases averted over a 20 year 
period) was measured in the entire model population, including both the mines and the 
labor sending communities, thus providing an estimate of the relative impact of mine-
targeted versus community-targeted vaccination. 
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Methods 
Model Development 
We developed an individual-based transmission model to characterize the transmission 
dynamics of TB in a model population consisting of the mines and the associated labor-
sending communities. The model (Web Fig. 1) features components that describe (i) the 
composition of mines and miners’ mixing patterns; (ii) natural history of TB; (iii) HIV 
prevalence and HIV-TB co-infection dynamics; (iv) demographic processes; and (v) 
mechanistic description of vaccines.  
Mines and labor-sending community: 
The model population consisted of permanent residents of the labor sending districts and 
the migratory sub-population of those districts that work in the mines (Web Fig. 1[A]). We 
assumed that a sizable fraction of the population (range explored: 20-70% of adult males) 
would consist of miners, who when employed, travel between the mines and the home 
community. To reflect this, individuals were modeled as taking one of two potential life 
history trajectories: those who become miners and those who do not. Individuals who 
become miners are modeled as eligible to work in the mines between the ages of 18 and 60. 
Once a miner turns 18, he becomes a career miner after an average wait-time for 
recruitment (τrecruit). After recruitment, employed miners spend a portion of their time 
working in the mine (mixing only with other miners) and the remainder of their time at 
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home (mixing with others in the labor-sending community). We assumed that miners 
actively working at the mine remain at the mine for an average specified time (τmine) 
before returning home, and upon returning home, remain at home for an average time 
(τhome) before returning to the mine (See Web Fig. 1A, right panel for model schematic, 
and Web Table 1 for parameters estimates used in the model.).  
Natural history of TB: 
We adapted previously developed models to describe the natural history of TB [6, 16,17]. 
(Web Fig. 1[B].) In our model, an individual’s TB status can be: uninfected (U); latently 
infected with TB (L); and infectious with active TB disease (A). Upon exposure to TB, 
uninfected individuals may either develop latent infection or progress immediately to 
develop active TB. Latently infected individuals can subsequently develop active TB 
disease, either by endogenous reactivation or by reinfection followed by rapid progression. 
TB transmission was modeled separately in the mines and in the labor-sending community. 
Within each setting, we assumed homogeneous mixing among individuals, such that the per 
capita hazard of infection was proportional to the number of infectious individuals in that 
setting multiplied by the setting-specific transmission rate. We define the transmission rate 
as the average number of secondary transmissions per infectious person-year.  Successful 
treatment of TB was modeled as return to the latent state. To capture age- and sex-specific 
differences in TB incidence, we allowed for separate rates of rapid progression to active TB 
after initial infection and reactivation after remote infection. These rates were modeled as 
piecewise constant functions of age; thus, in any given model simulation, we assume four 
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different baseline rates (male/female, older/younger). The values of these four rates, as well 
as the age at which the transition from lower to higher rates occurs, are assumed to be 
modified by HIV and are fit to match the age-specific TB incidence data. 
HIV prevalence, ART coverage, and HIV-TB co-infection: 
We modeled the acquisition of HIV infection to be age- and sex-dependent, but independent 
of TB status. We allowed for separate HIV acquisition rates for males and females 
reflective of differences in HIV prevalence between the two sexes. We modeled the rates as 
piecewise functions of age, categorized as 2-15, 15-25, and 25-40 years old. HIV infection 
was modeled to sequentially progress through four stages, differentiated by CD4+ T-cell 
counts: (i) > 500; (ii) 350-500; (iii) 200-350; and (iv) < 200. (Web Fig. 1[B]). On the basis 
of literature estimates [17], we assumed that in the absence of treatment, individuals spend 
two years on average in each stage. We also included antiretroviral therapy (ART), 
assuming that the rate at which individuals received ART depended on their CD4+ counts 
and fitting these rates to age-specific ART coverage among adults in South Africa.  
We assumed that HIV increased the risk of TB disease by increasing both the risk of rapid 
progression and reactivation of latent infection. We assumed that, compared to HIV-
negative individuals, the incidence of TB would be 2, 4, 8, and 16 times higher among HIV-
positive individuals with CD4+ counts >500, 350-500, 200-350, and <200, respectively [18-
21]. Finally, we assumed HIV-specific mortality rates of 0.1/year for individuals with 
CD4+ counts higher than 200, and 0.35/year in individuals with CD4+ counts less than 
200 [22].  
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Demography: 
The population was modeled to have a per capita birth rate and an age-specific mortality 
rate, which was based on a Siler mortality model [23]. Individuals with active TB were 
additionally subject to TB-specific mortality (μTB), HIV-positive individuals were 
additionally subject to HIV-specific mortality, and HIV-positive individuals with active TB 
were additionally subject to both. 
Vaccines: 
The characteristics of the modeled vaccine were instantiated in consultation with experts at 
the Aeras Foundation, as those most useful to represent actual vaccines in development. We 
modeled a post-infection vaccine that prevents progression to TB disease, but does not 
prevent TB infection. This hypothetical, emblematic vaccine protects individuals against 
TB disease by preventing rapid progression following recent exposure or re-exposure, and 
by preventing reactivation of previously acquired latent TB infection. We assumed the 
vaccine to have 60% efficacy regardless of HIV status, with a protection lasting 10 years on 
average. We define vaccine efficacy in a biological sense, as the percentage of independent 
potential disease-causing events that would be averted by a vaccine. This definition of 
efficacy is not necessarily equivalent to efficacy in an epidemiological sense (as would be 
measured in a clinical trial), where each trial participant may experience more than one 
disease-causing event. 
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Data and Model Calibration 
We used multiple sources of data to sequentially calibrate different components of the 
model. For the demographic model, we assumed a constant per capita birth rate, and an 
age-specific background mortality model fitted to the South African age-specific mortality 
rates in 2011 [24]. For the HIV model, we fit age- and sex-specific HIV acquisition rates 
and ART treatment rates to reflect the population level prevalence of HIV and ART 
coverage in 2011 [25]. Comparisons between the data and model simulations are reported in 
Web Table 1 and shown in Fig. 1. 
We used data collected during the Thibela TB study [7, 26] to inform the model population. 
The Thibela TB study enrolled 15 mine clusters across three South African provinces: 
Gauteng, North West, and Free State. The miners were almost exclusively male (females < 
1%), with more than 60% of miners falling between the ages of 30 and 50. (Web Fig 2[B]) 
Reported TB incidence at the start of the study was 3,460 per 100,000/year. (Fig 1[D]) We 
identified 4 districts across 2 South African provinces: Ugu and Sisonke in Kwa-Zulu Natal, 
and OR Tambo and Alfred Nzo in Eastern Cape, as communities likely to be representative 
of the labor-sending communities serving the Thibela TB mines, and from which data could 
be readily accessed. We collected demographic data from Statistics South Africa [27] and 
TB notification rates in these districts from the Annual Tuberculosis Report of South Africa 
[28] (Fig. 1[D]). We observed that, while the average TB incidence in the labor-sending 
communities was 1,230 per 100,000/year (almost one-third of that in the mines), the TB 
incidence among middle-aged males in those communities was generally above 3,000 per 
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100,000/year (Fig. 1, solid blue bars in panel C versus solid bar in panel D). Finally, we 
assumed effects of HIV on TB incidence in both mines and the labor-sending community as 
described above [18-21]. (Fig. 1[E]) 
We fit the model to reflect data elements concerning (1) age- and sex-specific TB 
incidence, (2) demographic composition of the mines, (3) TB incidence in the mines, and 
(4) HIV-TB coinfection dynamics. We first generated 216,000 parameter sets, where each 
parameter was sampled from a reasonable range using Latin hypercube sampling. For each 
parameter set, we simulated the model, first without HIV until an approximate equilibrium 
was reached, and then with HIV dynamics in the final 30 years. We then selected the 
parameter sets that generated simulations that matched all four sets of data elements to 
within a tolerance of +/-35% of the reported value. We used these selected parameter sets as 
viable simulations, and used them to estimate the impact of vaccination. 
Vaccine dynamics 
We simulated two 20-year vaccination campaigns; (i) mine-targeted vaccination strategy, 
where vaccines were administered to all miners, including new miners at recruitment and 
current miners at their medical examination as they return to the mines; and (ii) community-
targeted vaccination strategy, where vaccines were delivered randomly to adults (10-60 
years) in the labor-sending population. The number of vaccine doses delivered per year was 
modeled to be equal in both strategies. We calculated the total number of TB cases averted 
in the total population (including both the mines and the labor-sending communities) over 
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20 years of vaccination, by comparing the simulations without vaccination against the 
simulations with each vaccination strategy.  
 
Sensitivity analyses 
To explore the sensitivity of the results to the model parameters, we calculated partial rank 
correlation coefficients [29] (PRCC) within the set of selected parameters, comparing the 
difference between the two vaccine delivery strategies, in terms of the number of TB cases 
averted over a 20-year period.  
Additionally, we conducted a series of sensitivity analyses to explore the sensitivity of the 
primary outcome to (i) uncertainty in vaccine efficacy (Web Appendix 1); (ii) vaccine 
uptake (Web Appendix 2); vaccine mechanism (Web Appendix 3); size of the mining 
population (Web Appendix 4); and impact of vaccination over time (Web Appendix 5). We 
also explored a scenario (Web Appendix 6) where heterogeneity in mixing was introduced 
in the population via household structure [30]. Finally, we explored an alternative scenario 
(Web Appendix 7) where the transmission rates within the mines were allowed to be higher 
than those within the labor-sending community, to allow for potentially higher effective 
contact rates in the mines. 
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Results 
Among 216,000 model simulations initialized with parameters sampled from distributions 
detailed in Web Table 1, 2,374 simulations matched the data within the pre-specified +/-
35% window. These selected simulations fit the epidemiological data reasonably well 
(Fig. 1C–F). In these data-consistent simulations, a median 22,000 (95% range: 9,660-
31,800) vaccines were delivered (Fig. 2[C&D]) per 100,000 over 20 years. When these 
vaccines were delivered to the labor-sending community, a median 5,510 (95% range: 
2,360-10,000) TB cases were averted over 20 years, or 0.254 cases averted per vaccine 
dose. By comparison, vaccination campaigns that targeted miners averted a median 8,090 
(95% range: 3,750-13,300) total TB cases (Fig. 2[A&B]), or 0.374 TB cases per vaccine 
dose (Fig. 2[E]).  
The mine-targeted strategy achieved higher impact than the community-targeted strategy in 
more than 99% of data-consistent simulations. Specifically, mine-targeted vaccination 
campaigns averted 1.46 (95% range: 1.13-1.91) times more TB cases than community-
targeted vaccination (Fig. 2[F]). The relative impact of targeting was expectedly more 
prominent in the targeted population (i.e., miners and adults) and persisted over time 
(relative impact in year 20 remained 1.41, 95% range: 1.08-1.9). (Web Appendix 5) 
The characteristic that most strongly influenced the primary outcome was the percentage of 
TB occurring in adult males (Fig. 3). Thus, where a greater proportion of incident TB 
occurs in adult men, mine-focused vaccination strategies are expected to have greater 
relative impact. The proportion of the population who became miners was inversely 
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associated with the primary outcome; when more members of the population were miners, 
the population-based vaccination strategy covered a larger proportion of miners, thus 
attenuating the relative impact of mine-targeted vaccination strategy. However, this effect 
was small (relative impact 1.48 in populations below the median mining population size 
versus 1.44 in populations above, Web Appendix 4).  
In an alternate model scenario (see Web Appendix 7),  in which transmission rates within 
the mines were allowed to be up to twice as large as in the labor-sending community, 
substantially fewer  proportions of simulations were consistent with the observed data (280 
out of 108,000, versus 2,374 out of 216,000). In those simulations, the relative impact of 
targeting the mines was not substantially affected (1.46 versus 1.54) and fell within the 
respective uncertainty ranges, suggesting that counterbalancing effects (e.g., reduced 
interactions between miners and the labor-sending community) are required under those 
scenarios to make the model fit the observed epidemiological data. 
Discussion 
In this work, we aimed to estimate the impact of vaccination strategies that targeted South 
African gold mines, relative to population-based strategies that targeted the labor-sending 
communities as a whole. We found that TB vaccines could have substantial impact in this 
setting, averting more than 0.25 cases of active TB per vaccine dose delivered. Vaccination 
strategies targeting miners were moderately (1.46 times) more effective than strategies 
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targeting the labor-sending communities, suggesting that occupationally targeted TB 
vaccination could be a useful strategy in high-burden settings like South Africa.  
The relative impact of mine-targeted vaccination was strongly dependent on the proportion 
of incident TB occurring in adult men, suggesting that such occupationally targeted 
strategies may be most effective when strong demographic gradients in TB incidence exist. 
In contrast, the relative impact of mine-targeted vaccination was less dependent on mine-
specific factors. Particularly, even when the mines were allowed to have higher TB 
transmission rates than the labor-sending community as a whole, the relative impact of 
mine-targeted vaccination remained essentially unchanged (See Web Appendix 7). 
Although the average TB incidence in the mining population was almost three times higher 
than the average TB incidence in the labor-sending community, the reported incidence in 
the mines was very similar to the TB incidence of adult men in the labor-sending 
population. Thus, the demographic composition of the mines is such that mine-targeted 
vaccination is essentially demographically targeted vaccination, i.e. vaccinating adult males 
in the labor-sending community would target people with the same expected TB incidence 
as the mine-targeted strategy. As a result, although targeting miners can have modest to 
moderate relative benefit, the underlying reason for this benefit may more reflect the 
disproportionate burden of TB among adult males, than the mines serving as true 
transmission hotspots in these communities.  
There are several potential reasons that miners, with their extreme occupational risk, might 
have similar TB incidence to young adult non-mining men in the labor-sending community. 
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These might include (1) a healthy worker effect (miners are more likely to acquire TB in the 
mines, but only healthy miners remain in employment); (2) socioeconomic factors (miners 
may be wealthier and/or healthier than the general community, which may offset any 
increased transmission in the mines themselves); and (3) secular trends (mines may have 
historically contributed to the higher population incidence of TB in the labor-sending 
communities, but conditions in the mines – including more intensive screening for TB – 
may have improved over time). Mines have operated for centuries, and the labor sending 
communities are likely to consist of retired miners, who may have high risk of TB due to 
factors such as silicosis, which might manifest only after long delays and hence be more 
prevalent in the community than the mines.  
Our study was limited by the data available to inform our model. Data on HIV prevalence 
were not available specifically for either the mines or the labor-sending districts, and we 
used national estimates for South Africa as proxies for both populations. Hence, our work 
did not account for potential differences in HIV-TB co-dynamics between the mines and the 
labor-sending community. Data on miners’ travel and mixing patterns were also limited, 
and our estimates for the amount of time spent in the mines were based on miners’ self-
reported responses to a survey questionnaire. The model did not account for mixing with 
peri-mining communities surrounding the mines, which might differ from the labor-sending 
communities. Our model did not include silica dust exposure and silicosis, which are strong 
independent risk factors for TB. The reported silicosis prevalence was relatively low (2.6%) 
in the miners in the Thibela TB study [7]. However, higher silicosis rates have previously 
been reported among miners, the prevalence of observable silicosis will increase with age, 
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and the Thibela TB mines may not represent the risk that miners in general experience. 
Finally, it should be noted that many vaccine characteristics (e.g., mechanism and duration 
of effect, heterogeneity in immunological “take", and efficacy, including differences 
between HIV-positive and HIV-negative individuals) are unknown and difficult to assess 
prior to implementation, even with a large-scale clinical trial. Our sensitivity analyses 
suggest that the relative value of mine-targeted vaccination is robust to uncertainty in 
vaccine efficacy, uptake, the size of targeted mining population, and moderate 
heterogeneity in mixing. We note that the effectiveness of the vaccine itself may be highly 
dependent on the mechanism of protection derived from the vaccine. In particular, pre-
infection vaccines that protect against infection only (and not TB disease) may have limited 
effectiveness when delivered to adults in a high-prevalance setting like South Africa, as the 
vast majority of individuals will be infected prior to vaccination, and the immunological 
effects of a vaccine in such individuals with some degree of existing natural immunity will 
likely remain uncertain. 
In summary, we found that, relative to a community-targeted strategy that focused on 
vaccinating adults in high-incidence labor-sending districts, a mine-targeted vaccination 
strategy provided moderate (1.45-fold) relative improvement. The absolute impact of TB 
vaccination (0.375 cases averted per dose), as well as the absolute impact of mine-targeted 
vaccination (over 8,000 TB cases per 100,000  over 20 years) was substantial, reflecting the 
tremendous incidence of TB in the overall population. The relative benefit achieved by 
targeting the mines largely reflects the fact that mine-focused strategies target a 
demographic group with higher TB incidence: adult males. Mines, in this context, may 
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serve as a mechanism via which demographic groups with higher risk of TB can be 
identified, and they may also be logistically more accessible than general adult populations.  
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Figure 1: Data, fitted model, and model simulations. [A] Population pyramids: data in 
shown in solid bars and model fits shown in hatched bars [B] Age and sex-specific HIV 
prevalence as reported in the South African prevalence survey [21] (shown in solid bars), 
and fitted prevalences (shown in hatched bars). [C] Age and sex-specific TB incidence (per 
100,000 per year) in the entire model population. Data represents notified TB cases 
aggregated in 4 districts (Ugu, Sisonke, OR Tambo, and Alfred Nzo) averaged between 
2011 and 2012, and scaled by the appropriate population (shown as solid red and blue bars 
for females and males, respectively) [28]. Model simulations are shown in hatched bars 
(bars represent medians, and vertical lines represent 95% range). [D] TB incidence (per 
100,000 per year) among miners: data in the Thibela TB mines are shown as a solid bar, 
and model simulations as a hatched bar. [E] We modeled the interaction between TB and 
HIV to manifest as an increased incidence of TB among HIV-positive individuals, by 
factors of 2, 4, 8 and 16 (shown by solid bars). The corresponding model simulations are 
shown by hatched bars.  
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Figure 2: Comparisons of mine and community targeted vaccines. [A] Cumulative TB 
cases averted over time by the two vaccination campaigns: red shows the campaign where 
the vaccine was targeted to the mines, and grey shows the campaign where the vaccine was 
targeted to the labor-sending community. [B] The two histograms show the distributions of 
total TB cases averted over the 20 year period. Community-targeted delivery (grey bars) 
averted a median of 5,510 cases (95% range:2,360-10,000), whereas, mine-targeted 
delivery (red bars) averted 8,090 cases (95% range: 3,750-13,300). Solid lines represent the 
medians of all data-consistent simulations, and dotted lines represent the 2.5th and 97.5th 
percentiles. [C] Cumulative vaccine doses delivered (the same for both delivery strategies) 
over time during the 20 year vaccine campaign. [D] Distribution of total vaccines delivered 
over 20 years (median: 22,000; 95% range: 9,660-31,800) [E] TB cases averted per vaccine 
delivered; grey for the community-targeted delivery (median: 0.254; 95% range: 0.178-
0.387), and red for the mine-targeted delivery (median: 0.374; 95% range: 0.274-0.527). [F] 
Impact of mine-targeted vaccine delivery on TB incidence over 20 years, relative to 
community-targeted delivery (median 1.46; 95% range: 1.13-1.91).   
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Figure 3: Partial rank correlation coefficients (PRCCs). Presented are partial rank 
correlation coefficients (PRCCs) comparing each model parameter (or parameter 
combination) with the primary outcome, total TB cases averted over 20 years of vaccination 
that was delivered to the mines relative to the vaccine that was delivered to the labor 
sending community. Only parameters with |PRCC|>.05 are shown, and only two factors 
(percentage of TB occurring in adult men, and percentage of the population engaged in 
mining) had absolute values of PRCC >0.15.  See Web Fig. 14 in the Web Appendix for 
PRCCs associated with the complete list of parameters. 
 
